ConforMIS Closes Initial Public Offering

ConforMIS Closes Initial Public Offering

ID: 405265

(Thomson Reuters ONE) -


BEDFORD, Mass., July 7, 2015 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS)
announced today the closing of its initial public offering of 10,350,000 shares
of common stock at a public offering price of $15.00 per share, before
underwriting discounts, including 1,350,000 shares of common stock issued upon
the exercise in full by the underwriters of their option to purchase additional
shares at the public offering price, less the underwriting discount.

J.P. Morgan and Deutsche Bank Securities acted as joint book-running managers
for the offering. Wells Fargo Securities, Canaccord Genuity and Oppenheimer &
Co. acted as co-managers.

A registration statement relating to these securities was declared effective by
the Securities and Exchange Commission on June 30, 2015. A copy of the final
prospectus relating to this offering may be obtained from: J.P. Morgan
Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204; or Deutsche Bank
Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, NY
10005-2836, or by email to prospectus.cpdg(at)db.com, or by telephone at +1 (800)
503-4611.

This press release shall not constitute an offer to sell or the solicitation of
an offer to buy, nor shall there be any sale of, these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification of these securities under the securities
laws of any such state or jurisdiction.

About ConforMIS

ConforMIS is a medical technology company that uses its proprietary iFit Image-
to-Implant technology platform to develop, manufacture and sell joint
replacement implants that are individually sized and shaped, or customized, to
fit each patient's unique anatomy. ConforMIS offers a broad line of customized




knee implants designed to restore the natural shape of a patient's knee.

CONTACT: Investor Contact:
         Paul Weiner
         ir(at)conformis.com
         (781) 345-9001

         Media Contacts:
         Bill Berry
         Berry & Company Public Relations
         Bberry(at)berrypr.com
         (212) 258-8881

         Lynn Granito
         Berry & Company Public Relations
         Lgranito(at)berrypr.com
         (212) 253-8881



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: ConforMIS via GlobeNewswire
[HUG#1935251]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  IFT and Schaeffler Engineering merge to form a single company BB Biotech AG earns after-tax profits of CHF 717 million in the first half-year 2015
Bereitgestellt von Benutzer: hugin
Datum: 07.07.2015 - 18:26 Uhr
Sprache: Deutsch
News-ID 405265
Anzahl Zeichen: 3132

contact information:
Town:

Bedford, MA



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 150 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ConforMIS Closes Initial Public Offering"
steht unter der journalistisch-redaktionellen Verantwortung von

ConforMIS (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von ConforMIS



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z